6 October 2020
From 1 November 2020, subject to formal approval from the Federal Executive Council, cost recovery arrangements will be extended to cannabis-related manufacture licences and permits under the Medicinal Cannabis Scheme.
27 July 2020
Changes to fees and charges related to the Medicinal Cannabis Scheme under the Narcotic Drugs Act 1967 commenced on 15 July 2020
29 June 2020

From 1 January 2021, proposed regulations would prohibit the importation of e-cigarettes containing vaporiser nicotine.

13 March 2020

The Office of Drug Control (ODC) is seeking comments from interested parties on the proposed Medicinal Cannabis Cost Recovery Framework. Closing date: 20 March 2020

22 January 2020

Submissions in response to the Office of Drug Control's (ODCs) Consultation on Single Licence Model close COB Monday 3 Feb

17 December 2019
The Office of Drug Control is implementing the 26 recommendations from the Report on the Review of the Narcotic Drugs Act 1967
5 September 2019
Professor McMillan's Final Report on the Review of the Act was tabled in Parliament on Thursday 5 September 2019
3 April 2019
A clarification of the processing rules around the timing of a medicinal cannabis licence and narcotics manufacturing licences
4 March 2019
Professor John McMillan AO appointed to review and report on the operation of the Narcotic Drugs Act 1967
21 December 2018
The TGA will be hosting public meetings in February 2019 in Sydney, Brisbane and Melbourne